                </a></li></ul></div><p><strong>Figure 3.  <span>ΔRS N-terminus mutations that improve splicing also increase the ability of ΔRS to bind IgM M1-M2.</span></strong></p><a id="article1.body1.sec2.sec3.fig1.caption1.p1" name="article1.body1.sec2.sec3.fig1.caption1.p1"></a><p>(A) Recombinant SF2/ASF and mutant proteins employed in the crosslinking assay. M: molecular-weight markers. (B) UV crosslinking of SF2/ASF and variant proteins to radiolabeled IgM M1-M2 RNA. BSA (lane 1), or purified recombinant SR proteins SF2/ASF (lane 2), ΔNSF2/ASF (lane 3), ΔRS (lane 4), ΔNΔRS (lane 5), ΔRS: Δ5-10 (lane 6), and ΔRS:R8E (lane 7) were incubated with uncapped IgM M1-M2 RNA prior to crosslinking, RNAse digestion, and separation of crosslinked adducts by SDS-PAGE.</p>
<span>THISISTHEEND
